{
    "Trade/Device Name(s)": [
        "Simplexa Bordetella Direct",
        "Simplexa Bordetella Positive Control Pack",
        "Simplexa Bordetella Direct MOL2750",
        "Simplexa Bordetella Positive Control Pack MOL2760"
    ],
    "Submitter Information": "DiaSorin Molecular LLC",
    "510(k) Number": "K183223",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173498"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZZ",
        "OOI"
    ],
    "Summary Letter Date": "November 16, 2018",
    "Summary Letter Received Date": "November 20, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Bordetella pertussis",
        "Bordetella parapertussis",
        "IS481 insertional element",
        "IS1001 insertional element"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Remel M4",
        "Remel M4RT",
        "Remel M5",
        "Remel M6",
        "UTM",
        "VTM",
        "Liquid Aimes (ESwab)"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON MDX instrument",
        "LIAISON MDX Studio Software",
        "Direct Amplification Disc"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Multiplex PCR",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "PCR-based detection",
        "Multiplex assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Reagent",
        "Disc",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin Molecular Simplexa Bordetella Direct and Positive Control Pack using real-time PCR for qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis from nasopharyngeal swabs",
    "Indications for Use Summary": "Qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis nucleic acids from nasopharyngeal swabs of patients with signs and symptoms of Bordetella respiratory infection using the LIAISON MDX instrument; control pack is for use with this assay only.",
    "fda_folder": "Microbiology"
}